"Designing Growth Strategies is in our DNA"

U.S. Hemostats Market Size, Share & Industry Analysis, By Product (Active Hemostats [Thrombin-based Hemostats, and Fibrin Sealants], Passive Hemostats [Plant-based, Animal-based, and Others], Combination Hemostats, and Others), By Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, and Others), By End-user (Hospitals & ASCs, Tactical Combat Casualty Care Centers, and Others), and Country Forecast, 2025-2032

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI108837

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate

CAGR of 6.5% from 2025-2032

Unit

Value (USD Billion)

Segmentation

By Product

  • Active Hemostats
    • Thrombin-based Hemostats
    • Fibrin Sealants
  • Passive Hemostats
    • Plant-based
    • Animal-based
    • Others
  • Combination Hemostats
  • Others

By Application

  • Trauma
  • Cardiovascular Surgery
  • General Surgery
  • Plastic Surgery
  • Orthopedic Surgery
  • Neurosurgery
  • Others

By End-user

  • Hospitals & ASCs
  • Tactical Combat Casualty Care Centers
  • Others

 

  • 2019-2032
  • 2024
  • 2019-2023
  • 96
  • Buy Now

    (Offer valid till 31st Dec 2025)

Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann